Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Search for FDA Guidance Documents

Search for FDA Guidance Documents

                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents Home
          Regulatory Information
          Search for FDA Guidance Documents
          Small Entity Compliance Guide: Bottled Water and UraniumSearch for FDA Guidance Documents SMALL ENTITY COMPLIANCE GUIDE
	Small Entity Compliance Guide: Bottled Water and Uranium
					
		
		April 2009


	Read the Federal Register Notice 

    Final

	  
	  
	Share
    Post
    Linkedin

    Email
    PrintDocket Number:
		    FDA-2009-D-0195
	    	    		    Issued by:
		    Guidance Issuing Office
          Center for Food Safety and Applied Nutrition


*This guidance represents the Food and Drug Administration's (FDA's) current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. You can use an alternative approach if the approach satisfies the requirements of the applicable statutes and regulations.*

Table of Contents

Introduction
	Background
	Questions and AnswersI. INTRODUCTION

On March 3, 2003, FDA published a direct final rule that amended its bottled water quality standard by establishing an allowable level for the contaminant uranium. As a consequence, bottled water manufacturers are required to monitor their finished bottled water products for uranium at least once each year under the current good manufacturing practice (CGMP) regulations for bottled water (21 CFR part 129). Bottled water manufacturers are also required to monitor their source water for uranium as often as necessary, but at least once every four years unless they meet the criteria for the source water monitoring exemptions under the CGMP regulations. FDA retained the existing allowable levels for combined radium-226/-228, gross alpha particle radioactivity, and beta particle and photon radioactivity(68 FR 9873) and listed analytical methods used for determining compliance with the quality standard for radionuclides in bottled water (68 FR 9873 at 9874). On June 9, 2003, FDA confirmed the effective date of December 8, 2003 for the direct final rule (68 FR 34272).

FFDA has prepared this Small Entity Compliance Guide in accordance with section 212 of the Small Business Regulatory Enforcement Fairness Act (Public Law 104-121). This guidance document restates in plain language the legal requirements of the March 3, 2003 direct final rule set forth in 21 CFR part 165 concerning the contaminant uranium. These regulations are binding and have the full force and effect of law.

FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidances describe the Agency's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited. The use of the word should in Agency guidances means that something is suggested or recommended, but not required.

II. BACKGROUND

Under section 410(b)(1) of the Federal Food, Drug, and Cosmetic Act, not later than 180 days before the effective date of a National Primary Drinking Water Regulation issued by the Environmental Protection Agency (EPA) for a contaminant under section 1412 of the Safe Drinking Water Act, FDA is required to issue a standard of quality regulation for that contaminant in bottled water or make a finding that such a regulation is not necessary to protect the public health because the contaminant is contained in water in public water systems but not in water used for bottled drinking water.

In the Federal Register of December 7, 2000 (65 FR 76708), EPA published a final rule establishing a maximum contaminant level (MCL) for uranium in public drinking water and retained the existing MCLs for combined radium-226/-228, gross alpha particle radioactivity, and beta particle and photon radioactivity. EPA took this action, in part, because studies have shown that long-term exposure to uranium in drinking water may adversely affect kidney function and result in increased risk of cancer. In response to this EPA rulemaking, FDA published the March 3, 2003 direct final rule. This direct final rule ensures that the minimum quality of bottled water, as affected by uranium, combined radium-226/-228, gross alpha particle radioactivity, and beta particle and photon radioactivity, remains comparable with the quality of public drinking water that meets EPA's standards.

III. QUESTIONS AND ANSWERS

What is the allowable level established by FDA for uranium in bottled water?

	The allowable level established by FDA for uranium in bottled water is 30 micrograms per liter of water. (21 CFR 165.110(b)(5)(i)(D)).
	What analytical methods are used for determining compliance with the quality standard for uranium in bottled water?

	The analytical methods used for determining compliance with the quality standard for uranium in bottled water are as follows:

	Method 7500-U B--"Radiochemical Method" which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed., and
		Method 7500-U C--"Isotopic Method" which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed.((21 CFR 165.110(b)(5)(ii)(D)).
	What analytical methods are used for determining compliance with the quality standard for combined radium-226/-228 in bottled water?

	The analytical methods used for determining compliance with the quality standard for combined radium-226/-228 are as follows:

	Method 7500-Ra B--"Precipitation Method," which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed., and
		Method 7500-Ra D--"Sequential Precipitation Method," which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed.(21 CFR 165.110(b)(5)(ii)(A)).
	What analytical method is used for determining compliance with the quality standard for gross alpha particle radioactivity in bottled water?

	The analytical method used for determining compliance with the quality standard for gross alpha particle radioactivity in bottled water is as follows:

	Method 7110 C--"Coprecipitation Method for Gross Alpha Radioactivity in Drinking Water," which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed.(21 CFR 165.110(b)(5)(ii)(B)).
	What analytical methods are used for determining compliance with the quality standard for beta particle and photon radioactivity in bottled water?

	The analytical methods used for determining compliance with the quality standard for beta particle and photon radioactivity in bottled water are as follows:

	Method 7500-Sr B--"Precipitation Method," which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed.,
		Method 7500-3 H B--"Liquid Scintillation Spectrometric Method," which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed., and
		Method 7120 B--"Gamma Spectroscopic Method," which is contained in "Standard Methods for the Examination of Water and Wastewater," 20th Ed.(21 CFR 165.110(b)(5)(ii)(C)).Related Information

Bottled Water/Carbonated Soft Drinks Guidance Documents & Regulatory InformationSubmit Comments
	   		  			    		Submit Comments Online
					You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
						If unable to submit comments online, please mail written comments to:
						Dockets Management
							Food and Drug Administration
							5630 Fishers Lane, Rm 1061
							Rockville, MD 20852
						All written comments should be identified with this document's docket number: FDA-2009-D-0195.

                                                                                  Content current as of:
      09/20/2018
         
                  
Regulated Product(s)
		 Food & Beverages
			  			     			  						              
			
			
			
			
			
						  Bottled WaterSearch for FDA Guidance Documents

        Search for FDA Guidance Documents

          
                        Search General and Cross-Cutting Topics Guidance Documents
          Advisory Committee Guidance Documents
          Import and Export Guidance Documents
          Cross-cutting Guidance Documents
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop